John J. Crowley - Jul 1, 2024 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Financial Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Stock symbol
CNTA
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/2/2024, 04:30 PM
Previous filing
Jun 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTA Share Option (right to buy) Award $0 +600K $0.00 600K Jul 1, 2024 Ordinary Shares 600K $8.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option shall vest and become exercisable on July 1, 2025 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Remarks:

Exhibit 24 - Power of Attorney